<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824689/" ref="ordinalpos=1136&amp;ncbi_uid=5464495&amp;link_uid=PMC3824689" image-link="/pmc/articles/PMC3824689/figure/fig2/" class="imagepopup">Figure 2.  From: IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">IBP activated the mTORC1 and mTORC2 signaling pathway in breast cancer cells. (<b>a</b> and <b>b</b>) qRT-PCR analysis of the mTOR signaling pathway-associated gene expression levels in MDA-MB-231 and MDA-MB-468 cells with different levels of IBP. (<b>c</b>) Those cells were analyzed for mTORC2 activity by immunoblotting for levels of p-mTOR Ser2481, p-Akt Ser473 and p-FOXO3a Thr32. (<b>d</b>) Cells were analyzed for mTORC1 activity by immunoblotting for levels of p-mTOR Ser2448, p-P70S6K Thr389 and p-4EBP1 Thr37/46</div></div>